To test potential contraceptive mechanisms of the selective P receptor modulator CDB-2914 in the early luteal phase.
Prospective randomized clinical trial.
Clinical research center.
Fifty-six women with regular cycles.
Women received a single dose of CDB-2914 (10, 50, or 100 mg) or placebo given… (More)